Search - tctmd.com

Displaying 101 - 120 of 231

Sort: Relevancy | Date

Manuscript

Moving Beyond Linear Formulas for Left Ventricular Mass in Aortic Valve Replacement

September 21, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

News Daily News

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Caitlin E. Cox

June 21, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

Percutaneous Transcatheter Aortic Valve Closure to Treat Left Ventricular Assist Device-Associated Aortic Regurgitation

Presenter: Shigeru Saito, Jonathon M. White, Abdullah Alenezi, MD

June 16, 2017

Presentation TVT 2017

Percutaneous Use of Septal Occluder for Management of Aortic Insufficiency Post-Left Ventricular Assist Device

Presenter: Shigeru Saito, Jonathon M. White, Sidakpal Panaich, MD

June 16, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

Transcatheter Aortic Valve Replacement for Aortic Insufficiency Post-left Ventricular Assist Device

Presenter: Albert Markus Kasel, Thomas Walther, Sidakpal Panaich, MD

June 15, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Shelley Wood

May 16, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Shelley Wood

March 24, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Features

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Michael O'Riordan

January 24, 2017

News Daily News

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Michael O'Riordan

December 19, 2016

News Daily News

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Todd Neale

November 08, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

Advertisement

Moving Beyond Linear Formulas for Left Ventricular Mass in Aortic Valve Replacement

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

Ultrasound May Prove Useful in Softening Calcified Bioprosthetic Valves

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Percutaneous Transcatheter Aortic Valve Closure to Treat Left Ventricular Assist Device-Associated Aortic Regurgitation

Percutaneous Use of Septal Occluder for Management of Aortic Insufficiency Post-Left Ventricular Assist Device

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Transcatheter Aortic Valve Replacement for Aortic Insufficiency Post-left Ventricular Assist Device

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content